Advertisement

ADVERTISEMENT

prostate cancer

Out-of-Pocket Costs of Oral Hormonal Therapies High for Patients With Prostate Cancer
Videos
Out-of-Pocket Costs of Oral Hormonal Therapies High for Patients With Prostate Cancer
02/18/2021
02/18/2021
Journal of Clinical Pathways
PTEN Loss of Function Associated With Worse Survival in Metastatic CRPC
Videos
PTEN Loss of Function Associated With Worse Survival in Metastatic CRPC
02/18/2021
02/18/2021
Journal of Clinical Pathways
Conference Coverage
Adverse Events in Patients With Prostate Cancer Receiving Apalutamide or Enzalutamide
02/15/2021
02/15/2021
Journal of Clinical Pathways
Conference Coverage
Real-World Cardiotoxicity of Abiraterone vs Enzalutamide for Prostate Cancer
02/15/2021
02/15/2021
Journal of Clinical Pathways
News
RT Added to ADT Cost-Effective vs ADT Alone for Metastatic Prostate Cancer
01/28/2021
01/28/2021
Journal of Clinical Pathways
AUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer
Guideline Updates
AUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer
06/30/2020
The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) released a new clinical practice guideline for the diagnosis and treatment of...
The American Urological Association (AUA), American Society for Radiation Oncology (ASTRO), and Society of Urologic Oncology (SUO) released a new clinical practice guideline for the diagnosis and treatment of...
The...
06/30/2020
Journal of Clinical Pathways
Consensus Recommendations for Germline Testing in Prostate Cancer
Guideline Updates
Consensus Recommendations for Germline Testing in Prostate Cancer
06/15/2020
A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...
A session entitled “Implementation of Germline Testing for Prostate Cancer” held at the Philadelphia Prostate Cancer Consensus Conference in 2019 provided novel recommendations for genetic testing. Germline testing...
A...
06/15/2020
Journal of Clinical Pathways
News
Addition of ADT, Brachytherapy to External Beam Radiotherapy for Localized Prostate Cancer
06/03/2020
Androgen deprivation therapy (ADT) should be considered a critical component of treatment for men with intermediate- and high-risk prostate cancer regardless of radiotherapy delivery method, according to new...
Androgen deprivation therapy (ADT) should be considered a critical component of treatment for men with intermediate- and high-risk prostate cancer regardless of radiotherapy delivery method, according to new...
...
06/03/2020
Journal of Clinical Pathways
News
At-Home PROs Offer Effective Approach for QoL Monitoring in Prostate Cancer Trials
05/30/2020
At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from ERT—a global data and technology company that helps minimize risk in clinical trials—shed light on the...
At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from ERT—a global data and technology company that helps minimize risk in clinical trials—shed light on the...
At the...
05/30/2020
Journal of Clinical Pathways
Interview
Prostate Cancer Treatment Varies Between General Population, Diagnosed Men
01/11/2019
JCP Editors
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
Prostate cancer is the second most common cancer among men in the United States, as well as the third leading cause of cancer-related death.1 More than 160,000 men are diagnosed with prostate cancer annually, and...
...
01/11/2019
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use